tradingkey.logo
tradingkey.logo
Search

Nxera Pharma Co - Achieves Second Development Milestone In Collaboration With Eli Lilly Targeting Metabolic Diseases

ReutersApr 8, 2026 11:31 PM

Nxera Pharma Co Ltd 4565.T:

  • NXERA PHARMA CO - ACHIEVES SECOND DEVELOPMENT MILESTONE IN COLLABORATION WITH ELI LILLY TARGETING METABOLIC DISEASES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI